HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,463,230 | +6.5% | 161,437 | +1.2% | 0.02% | +15.0% |
| Q2 2023 | $13,579,320 | +4.9% | 159,494 | +1.9% | 0.02% | 0.0% |
| Q1 2023 | $12,947,563 | +48.8% | 156,466 | +41.5% | 0.02% | +33.3% |
| Q4 2022 | $8,699,556 | +29.2% | 110,611 | +21.6% | 0.02% | +36.4% |
| Q3 2022 | $6,731,000 | -22.6% | 90,935 | -31.8% | 0.01% | -21.4% |
| Q2 2022 | $8,691,000 | -30.6% | 133,342 | -32.7% | 0.01% | -17.6% |
| Q1 2022 | $12,530,000 | +327.5% | 198,192 | +258.6% | 0.02% | +325.0% |
| Q4 2021 | $2,931,000 | +111.9% | 55,262 | +182.0% | 0.00% | +100.0% |
| Q3 2021 | $1,383,000 | +0.7% | 19,598 | -4.9% | 0.00% | 0.0% |
| Q2 2021 | $1,374,000 | -65.1% | 20,617 | -41.8% | 0.00% | -66.7% |
| Q1 2021 | $3,935,000 | +344.1% | 35,449 | +374.8% | 0.01% | +500.0% |
| Q4 2020 | $886,000 | +33.4% | 7,466 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $664,000 | -85.3% | 7,607 | -84.9% | 0.00% | -88.9% |
| Q2 2020 | $4,516,000 | -42.4% | 50,413 | -35.9% | 0.01% | -47.1% |
| Q1 2020 | $7,843,000 | -53.2% | 78,692 | -46.0% | 0.02% | -32.0% |
| Q4 2019 | $16,742,000 | -18.8% | 145,710 | -10.8% | 0.02% | -24.2% |
| Q3 2019 | $20,609,000 | -11.4% | 163,375 | -15.5% | 0.03% | -8.3% |
| Q2 2019 | $23,267,000 | -39.2% | 193,339 | -55.8% | 0.04% | -43.8% |
| Q1 2019 | $38,299,000 | -5.5% | 437,803 | +8.1% | 0.06% | -9.9% |
| Q4 2018 | $40,538,000 | +22.5% | 405,179 | +40.3% | 0.07% | +44.9% |
| Q3 2018 | $33,082,000 | +38.7% | 288,729 | +8.6% | 0.05% | +36.1% |
| Q2 2018 | $23,844,000 | +32.1% | 265,876 | +7.8% | 0.04% | +33.3% |
| Q1 2018 | $18,052,000 | +108.4% | 246,747 | +65.4% | 0.03% | +125.0% |
| Q4 2017 | $8,663,000 | +112.4% | 149,156 | +64.1% | 0.01% | +100.0% |
| Q3 2017 | $4,078,000 | +15.7% | 90,892 | +1.8% | 0.01% | +20.0% |
| Q2 2017 | $3,526,000 | -13.4% | 89,292 | -11.0% | 0.01% | -16.7% |
| Q1 2017 | $4,070,000 | -2.1% | 100,322 | -3.0% | 0.01% | -14.3% |
| Q4 2016 | $4,157,000 | -3.1% | 103,412 | -12.7% | 0.01% | 0.0% |
| Q3 2016 | $4,290,000 | -25.2% | 118,462 | -40.2% | 0.01% | -30.0% |
| Q2 2016 | $5,738,000 | +31.6% | 197,932 | +58.8% | 0.01% | +25.0% |
| Q1 2016 | $4,360,000 | +14.4% | 124,632 | +5.4% | 0.01% | +14.3% |
| Q4 2015 | $3,812,000 | +1.4% | 118,232 | +1.6% | 0.01% | 0.0% |
| Q3 2015 | $3,760,000 | -22.9% | 116,332 | -1.3% | 0.01% | -22.2% |
| Q2 2015 | $4,874,000 | -6.5% | 117,832 | +1.5% | 0.01% | 0.0% |
| Q1 2015 | $5,214,000 | +18.1% | 116,082 | -1.6% | 0.01% | +12.5% |
| Q4 2014 | $4,415,000 | +6.3% | 117,982 | -0.8% | 0.01% | 0.0% |
| Q3 2014 | $4,155,000 | -4.4% | 118,982 | -3.4% | 0.01% | 0.0% |
| Q2 2014 | $4,346,000 | +12.2% | 123,196 | +3.6% | 0.01% | +14.3% |
| Q1 2014 | $3,874,000 | -21.7% | 118,882 | +1.3% | 0.01% | -30.0% |
| Q4 2013 | $4,945,000 | +4.7% | 117,382 | -0.8% | 0.01% | 0.0% |
| Q3 2013 | $4,721,000 | -1.0% | 118,382 | +2.7% | 0.01% | -9.1% |
| Q2 2013 | $4,767,000 | – | 115,282 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |